Search Results 1061-1070 of 36104 for breast cancer
Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.
People who seek care at Mayo Clinic have a chance to participate in clinical trials studying the latest techniques for breast cancer diagnosis and treatment.
This study will examine the safety and tolerability of SGN-LIV1A in patients with metastatic breast cancer. SGN-LIV1A will be given every 3 weeks alone or in ...
The Mayo Clinic Center for Individualized Medicine's BEAUTY2 study uses the genome as a guide to test drugs for chemotherapy-resistant breast cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact.